(Q73269139)

English

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity

scientific article published on 01 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity (English)

1 reference

10.1016/S0360-3016(03)00081-6

https://api.crossref.org/works/10.1016/S0360-3016(03)00081-6

24 December 2023

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0360-3016(03)00081-6

https://api.crossref.org/works/10.1016/S0360-3016(03)00081-6

24 December 2023

Hideya Yamazaki

7

object named as

Hideya Yamazaki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694841

24 December 2023

author name string

Yasuo Yoshioka

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Takayuki Nose

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ken Yoshida

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ryoong Jin Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Yuji Yamada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Eiichi Tanaka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Takehiro Inoue

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Toshihiko Inoue

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301603000816?httpAccept=text/xml

1 reference

10.1016/S0360-3016(03)00081-6

https://api.crossref.org/works/10.1016/S0360-3016(03)00081-6

24 December 2023

https://api.elsevier.com/content/article/PII:S0360301603000816?httpAccept=text/plain

1 reference

10.1016/S0360-3016(03)00081-6

https://api.crossref.org/works/10.1016/S0360-3016(03)00081-6

24 December 2023

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

213-220

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Needle displacement during HDR brachytherapy in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900081-6

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy

17

1 reference

10.1016/S0360-3016(03)00081-6

https://api.crossref.org/works/10.1016/S0360-3016(03)00081-6

24 December 2023

Identifiers

10.1016/S0360-3016(03)00081-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73269139&oldid=2035550993"